New handbook on health economic assessments of medical devices

18 August 2022 - TLV carries out health economic assessments of medical technology products at the request of the Medical Technology ...

Read more →

Health economic assessment of Abecma in the treatment of multiple myeloma

6 May 2022 - TLV has produced a health economic assessment for the regions for Abecma (idecabtagene vicleucel).  ...

Read more →

Health economic assessment of Blenrep in the treatment of multiple myeloma

6 May 2022 - TLV has produced a health economic assessment for the regions for the drug Blenrep (belantamab mafodotin).  ...

Read more →

Annual report 2021: more Government assignments and increased EU cooperation on TLV

23 February 2022 - In 2021, the Swedish Dental and Pharmaceutical Benefits Agency, TLV, reported a number of urgent government assignments ...

Read more →

Update of handbook for companies applying for a subsidy

18 June 2021 - The Swedish Dental and Pharmaceutical Benefits Agency, TLV, has updated parts of the handbook for companies ...

Read more →

Health economic assessment of Qarziba in patients with high-risk neuroblastoma

21 April 2021 - TLV has produced a health economic assessment for the regions for the drug Qarziba (dinutuximab beta).  ...

Read more →